Fidelity Investments’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Buy |
17,691
+1,801
| +11% | +$26K | ﹤0.01% | 3222 |
|
|
2025
Q1 | $110K | Buy |
15,890
+1,031
| +7% | +$7.11K | ﹤0.01% | 3517 |
|
|
2024
Q4 | $78.8K | Sell |
14,859
-295
| -2% | -$1.57K | ﹤0.01% | 3650 |
|
|
2024
Q3 | $55.3K | Buy |
+15,154
| New | +$55.3K | ﹤0.01% | 3733 |
|
|
2023
Q4 | – | Sell |
-18
| Closed | -$26 | – | 5694 |
|
|
2023
Q3 | $26 | Sell |
18
-10
| -36% | -$14 | ﹤0.01% | 5047 |
|
|
2023
Q2 | $43 | Sell |
28
-11
| -28% | -$17 | ﹤0.01% | 5043 |
|
|
2023
Q1 | $60 | Buy |
39
+8
| +26% | +$12 | ﹤0.01% | 4951 |
|
|
2022
Q4 | $52 | Buy |
31
+19
| +158% | +$32 | ﹤0.01% | 4938 |
|
|
2022
Q3 | $0 | Sell |
12
-11,590
| -100% | – | ﹤0.01% | 5499 |
|
|
2022
Q2 | $19K | Buy |
11,602
+6,027
| +108% | +$9.87K | ﹤0.01% | 3905 |
|
|
2022
Q1 | $14K | Buy |
5,575
+5,546
| +19,124% | +$13.9K | ﹤0.01% | 4139 |
|
|
2021
Q4 | $0 | Sell |
29
-642
| -96% | – | ﹤0.01% | 5035 |
|
|
2021
Q3 | $4K | Hold |
671
| – | – | ﹤0.01% | 3876 |
|
|
2021
Q2 | $7K | Sell |
671
-24,788
| -97% | -$259K | ﹤0.01% | 3655 |
|
|
2021
Q1 | $238K | Buy |
+25,459
| New | +$238K | ﹤0.01% | 2792 |
|
|
2020
Q1 | – | Sell |
-750
| Closed | -$3K | – | 4335 |
|
|
2019
Q4 | $3K | Buy |
+750
| New | +$3K | ﹤0.01% | 3526 |
|